A: Some patients report noticeable facial changes while others experience no changes
Key finding: Ipamorelin increased lean body mass by 2.1kg, reduced fat mass by 2.7kg, improved body composition ratio by 18%
Patients with and without anti-tesamorelin IgG antibodies had similar mean reductions in visceral adipose tissue (VAT) and IGF-1 response suggesting that the presence of antibodies did not alter the efficacy of tesamorelin
Nevertheless, robust clinical evidence in PsA remains limited, underscoring the need for dedicated randomized controlled trials to clarify the effects of GLP-1RAs on joint inflammation, disease progression, and long-term clinical outcomes
Veterinarians recommend that treats should be no more than 10% of a pet's daily calories 7
All of the drugmakers face the prospect of more local competition in China, where Novo's patent on Wegovy's active ingredient semaglutide expires in 2026 and companies like CSPC Pharmaceutical Group and Hangzhou Jiuyuan Genetic Biopharmaceutical Co are developing their own versions of the drug